Home

Biologics for Aesthetic Practices.

Exosomes and Wharton’s Jelly applied in conjunction with the procedures you already offer, sourced directly from an FDA-registered lab with full documentation on every order.

Your patients are asking for it. Your competitors are adding it.

Patient demand for biologic-enhanced aesthetics is growing across every segment of med spa services. Providers integrating biologics report stronger retention and increased revenue within their existing service menus, without adding new procedures or overhead.

What separates the providers gaining ground: knowing their source, having their documentation, and being able to answer questions their patients bring in from their own research.

Regenerative aesthetics

How Biologics Integrate Into Your Services

Microneedling

Exosomes applied during microneedling. Rich in natural human-derived hyaluronic acid and ECM proteins homologous to those naturally present in healthy skin tissue.

Hair Restoration

Applied to the scalp in conjunction with provider-directed hair protocols. Contains natural collagens and 300+ biologically active growth factors naturally present in healthy scalp tissue, which decline with age.

PRP Replacement

Adds over 300 distinct biologically active proteins and growth factors, the building blocks naturally present in healthy tissue, concentrated in every cc.

Aesthetic Rejuvenation

Natural human-derived hyaluronic acid supports hydration. Chondroitin sulfate is naturally present in healthy connective tissue. α-KLOTHO — a naturally occurring protein that declines with age — is present in high concentrations in PSF-003®-derived exosomes.

CO₂ Laser

Applied post-laser at provider discretion. Natural collagens and human-derived hyaluronic acid are homologous to components naturally present in healthy skin tissue.

Facial Treatments

Applied in conjunction with facial procedures. Natural collagens, human-derived hyaluronic acid, and chondroitin sulfate from amniotic fluid and Wharton’s jelly, components naturally present in healthy skin that decline with age.

Revenue Potential

Model the financial impact of adding regenerative biologics to your med spa.

$500–2K
Avg Ticket
15–30
Monthly Volume
$90–720K
Annual Potential

Products for Med Spas

Exosomes
  • ~350 billion exosomes per cc
  • 300+ biologically active cytokines and growth factors
  • Natural human Klotho
  • Human-derived hyaluronic acid
  • Chondroitin sulfate
Wharton's Jelly
  • 200+ biologically active cytokines and growth factors
  • Natural collagens
  • Human-derived hyaluronic acid
  • Chondroitin sulfate
FDA
FDA Registered
cGMP
cGMP Facility
ISO
Class 5 & 7 Cleanroom
MoCRA
MoCRA Compliant
Ethically Sourced

Ready to upgrade your med spa?

Start integrating regenerative biologics into the treatments you already offer. Same procedures, better outcomes, premium positioning.

Built by AUSTAN

DISCLAIMER

Sōlix does not own, operate, or manage any laboratory, manufacturing, or compounding facility. All biological products available through this platform are manufactured, processed, and distributed by our independently owned and operated FDA-registered laboratory partners. Sōlix does not distribute, ship, handle, or take possession of any biological product at any point in the supply chain.

Sōlix operates as a provider platform that offers licensed healthcare practitioners access to product ordering, clinical education, implementation support, marketing resources, and business integration tools designed to help practices incorporate regenerative biologics into their clinical offerings.

Sōlix is not a compounding pharmacy or chemical compounding facility as defined under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. Sōlix does not compound, manufacture, repackage, or relabel any drug or biological product.

Sōlix resources are for educational and informational purposes only. Providers are responsible for their own regulatory compliance, licensing, and insurance. Sōlix assumes no liability for how materials are applied in practice.

FDA DISCLAIMER

The statements made on this website have not been evaluated by the U.S. Food and Drug Administration. The products and services referenced on this platform are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Biological products, including but not limited to stem cells, exosomes, Wharton's Jelly, and amniotic tissue allografts, are minimally manipulated human cells, tissues, and cellular and tissue-based products (HCT/Ps) regulated under 21 CFR Part 1271. These products are intended for homologous use only and are administered at the sole discretion of a licensed healthcare provider following individual patient assessment. Results may vary. No guarantees of specific outcomes are made or implied.

All medical decisions, including the use of regenerative biologics, should be made in consultation with a qualified healthcare professional. Sōlix makes no medical claims and assumes no liability for clinical outcomes resulting from the use of products ordered through this platform.

Sōlix provides a provider platform and sales CRM for ordering regenerative human biologics, managing provider relationships, and integrating third-party services including Google Calendar for scheduling and appointment management. For details on how we handle your data, see our Privacy Policy.

Terms & ConditionsPrivacy Policy